Correlation Between Precigen and Tarsus Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Precigen and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Precigen and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Precigen and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on Precigen and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Precigen with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Precigen and Tarsus Pharmaceuticals.

Diversification Opportunities for Precigen and Tarsus Pharmaceuticals

-0.49

Correlation Coefficient

Precigen  Tarsus Pharmaceuticals

Very good diversification

The 3 months correlation between Precigen and Tarsus is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Precigen and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and Precigen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Precigen are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of Precigen i.e., Precigen and Tarsus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Precigen and Tarsus Pharmaceuticals

Given the investment horizon of 90 days Precigen is expected to generate 1.97 times more return on investment than Tarsus Pharmaceuticals. However, Precigen is 1.97 times more volatile than Tarsus Pharmaceuticals. It trades about 0.24 of its potential returns per unit of risk. Tarsus Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest  76.00  in Precigen on December 20, 2024 and sell it today you would earn a total of  103.00  from holding Precigen or generate 135.53% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Precigen  vs.  Tarsus Pharmaceuticals

Precigen

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Precigen are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady technical and fundamental indicators, Precigen displayed solid returns over the last few months and may actually be approaching a breakup point.

Tarsus Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Tarsus Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Tarsus Pharmaceuticals is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Precigen and Tarsus Pharmaceuticals

The main advantage of trading using opposite Precigen and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Precigen position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.

The idea behind Precigen and Tarsus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.